Disc Medicine, Inc. 8-K

What Happened
Disc Medicine, Inc. (IRON) filed a Form 8-K on May 5, 2026 reporting its results of operations and financial condition for the quarter ended March 31, 2026 and providing a corporate update. The company furnished a press release announcing the results as Exhibit 99.1 to the 8-K. The report was signed by CEO John Quisel, J.D., Ph.D.

Key Details

• Filing date: May 5, 2026 (Form 8-K, Item 2.02 and Item 9.01).
• Reporting period: Quarter ended March 31, 2026 (Q1 2026 quarterly results).
• Press release: Furnished as Exhibit 99.1 to the 8-K (contains the detailed announcement).
• Authorized signatory: John Quisel, Chief Executive Officer, signed the filing.

Why It Matters
This filing informs investors that Disc Medicine has publicly reported its Q1 2026 quarterly results and provided a corporate update; the substantive financial figures and operational details are contained in the furnished press release (Exhibit 99.1). Retail investors should review that press release and the company’s subsequent SEC filings for revenue, expenses, cash runway, guidance, and any program updates to assess near-term financial health and execution.